Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry

PD. Lambiase, C. Barr, DA. Theuns, R. Knops, P. Neuzil, JB. Johansen, M. Hood, S. Pedersen, S. Kääb, F. Murgatroyd, HL. Reeve, N. Carter, L. Boersma, . ,

. 2014 ; 35 (25) : 1657-65.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu hodnotící studie, časopisecké články, multicentrická studie, pozorovací studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15014449

AIMS: The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventional transvenous ICD system to minimize intravascular lead complications. There are limited data describing the long-term performance of the S-ICD. This paper presents the first large international patient population collected as part of the EFFORTLESS S-ICD Registry. METHODS AND RESULTS: The EFFORTLESS S-ICD Registry is a non-randomized, standard of care, multicentre Registry designed to collect long-term, system-related, clinical, and patient reported outcome data from S-ICD implanted patients since June 2009. Follow-up data are systematically collected over 60-month post-implant including Quality of Life. The study population of 472 patients of which 241 (51%) were enrolled prospectively has a mean follow-up duration of 558 days (range 13-1342 days, median 498 days), 72% male, mean age of 49 ± 18 years (range 9-88 years), 42% mean left ventricular ejection fraction. Complication-free rates were 97 and 94%, at 30 and 360 days, respectively. Three hundred and seventeen spontaneous episodes were recorded in 85 patients during the follow-up period. Of these episodes, 169 (53%) received therapy, 93 being for Ventricular Tachycardia/Fibrillation (VT/VF). One patient died of recurrent VF and severe bradycardia. Regarding discrete VT/VF episodes, first shock conversion efficacy was 88% with 100% overall successful clinical conversion after a maximum of five shocks. The 360-day inappropriate shock rate was 7% with the vast majority occurring for oversensing (62/73 episodes), primarily of cardiac signals (94% of oversensed episodes). CONCLUSION: The first large cohort of real-world data from an International patient S-ICD population demonstrates appropriate system performance with clinical event rates and inappropriate shock rates comparable with those reported for conventional ICDs. Clinical trial registration URL: http://www.clinicaltrials.gov. Unique identifier NCT01085435.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014449
003      
CZ-PrNML
005      
20220126132402.0
007      
ta
008      
150420s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/eurheartj/ehu112 $2 doi
035    __
$a (PubMed)24670710
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Lambiase, Pier D $u Cardiology Department, The Heart Hospital, Institute of Cardiovascular Science, University College London, 16-18 Westmoreland Street, W1G 8PH London, UK pier.lambiase@uclh.nhs.uk.
245    10
$a Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry / $c PD. Lambiase, C. Barr, DA. Theuns, R. Knops, P. Neuzil, JB. Johansen, M. Hood, S. Pedersen, S. Kääb, F. Murgatroyd, HL. Reeve, N. Carter, L. Boersma, . ,
520    9_
$a AIMS: The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventional transvenous ICD system to minimize intravascular lead complications. There are limited data describing the long-term performance of the S-ICD. This paper presents the first large international patient population collected as part of the EFFORTLESS S-ICD Registry. METHODS AND RESULTS: The EFFORTLESS S-ICD Registry is a non-randomized, standard of care, multicentre Registry designed to collect long-term, system-related, clinical, and patient reported outcome data from S-ICD implanted patients since June 2009. Follow-up data are systematically collected over 60-month post-implant including Quality of Life. The study population of 472 patients of which 241 (51%) were enrolled prospectively has a mean follow-up duration of 558 days (range 13-1342 days, median 498 days), 72% male, mean age of 49 ± 18 years (range 9-88 years), 42% mean left ventricular ejection fraction. Complication-free rates were 97 and 94%, at 30 and 360 days, respectively. Three hundred and seventeen spontaneous episodes were recorded in 85 patients during the follow-up period. Of these episodes, 169 (53%) received therapy, 93 being for Ventricular Tachycardia/Fibrillation (VT/VF). One patient died of recurrent VF and severe bradycardia. Regarding discrete VT/VF episodes, first shock conversion efficacy was 88% with 100% overall successful clinical conversion after a maximum of five shocks. The 360-day inappropriate shock rate was 7% with the vast majority occurring for oversensing (62/73 episodes), primarily of cardiac signals (94% of oversensed episodes). CONCLUSION: The first large cohort of real-world data from an International patient S-ICD population demonstrates appropriate system performance with clinical event rates and inappropriate shock rates comparable with those reported for conventional ICDs. Clinical trial registration URL: http://www.clinicaltrials.gov. Unique identifier NCT01085435.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a srdeční arytmie $x terapie $7 D001145
650    _2
$a dítě $7 D002648
650    _2
$a defibrilátory implantabilní $x škodlivé účinky $x normy $x statistika a číselné údaje $7 D017147
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prospektivní studie $7 D011446
650    _2
$a implantace protézy $x metody $7 D019919
650    _2
$a kvalita života $7 D011788
650    _2
$a registrace $7 D012042
650    _2
$a čas zasáhnout při rozvinutí nemoci $7 D061665
650    _2
$a výsledek terapie $7 D016896
650    _2
$a mladý dospělý $7 D055815
655    _2
$a hodnotící studie $7 D023362
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Barr, Craig $u Cardiology Department, Russells Hall Hospital, Dudley, UK.
700    1_
$a Theuns, Dominic A M J $u Department of Clinical Electrophysiology, Erasmus Medical Center, Rotterdam, The Netherlands.
700    1_
$a Knops, Reinoud $u Department of Cardiology and Electrophysiology, Academic Medical Center, Amsterdam, The Netherlands.
700    1_
$a Neuzil, Petr $u Department of Cardiology, Homnolka Hospital, Prague, Czech Republic.
700    1_
$a Johansen, Jens Brock $u Department of Cardiology, Electrophysiology Section, Odense University Hospital, Odense, Denmark.
700    1_
$a Hood, Margaret $u Auckland City Hospital, Auckland, New Zealand.
700    1_
$a Pedersen, Susanne $u Center of Research on Psychology in Somatic Diseases, Department of Medical and Clinical Psychology, Tilburg University, Tilburg, The Netherlands Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
700    1_
$a Kääb, Stefan $u Division of Electrophysiology, Campus Grosshadern, University of Munich, Munich, Germany.
700    1_
$a Murgatroyd, Francis D. $u King's College Hospital, London, UK. $7 xx0268928
700    1_
$a Reeve, Helen L $u Boston Scientific Corporation, St Paul MN, USA.
700    1_
$a Carter, Nathan $u Boston Scientific Corporation, St Paul MN, USA.
700    1_
$a Boersma, Lucas $u St Antonius Ziekenhuis, Nieuwegein, The Netherlands.
700    1_
$a ,
773    0_
$w MED00009622 $t European heart journal $x 1522-9645 $g Roč. 35, č. 25 (2014), s. 1657-65
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24670710 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20220126132357 $b ABA008
999    __
$a ok $b bmc $g 1072030 $s 897327
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 35 $c 25 $d 1657-65 $i 1522-9645 $m European heart journal $n Eur Heart J $x MED00009622
LZP    __
$a Pubmed-20150420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...